Meta-analysis comparing torsemide versus furosemide in patients with heart failure

B Abraham, M Megaly, M Sous… - The American journal of …, 2020 - Elsevier
Although torsemide's oral bioavailability and half-life theoretically render it a more efficient
diuretic than furosemide, the clinical outcomes of torsemide compared with furosemide …

Torsemide versus furosemide and intermediate-term outcomes in patients with heart failure: an updated meta-analysis

JA Miles, BK Hanumanthu, K Patel… - Journal of …, 2019 - journals.lww.com
Aims Loop diuretics have become a mainstay of chronic heart failure management.
Furosemide and torsemide are the two most common loop diuretics; nevertheless, there is …

Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital

RJ Mentz, J Buggey, M Fiuzat, MK Ersbøll… - Journal of …, 2015 - journals.lww.com
Furosemide has historically been the primary loop diuretic in heart failure patients despite
data suggesting potential advantages with torsemide. We used the Duke Echocardiography …

Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure

MD Murray, MM Deer, JA Ferguson, PR Dexter… - The American journal of …, 2001 - Elsevier
PURPOSE: Because the bioavailability of oral furosemide is erratic and often incomplete, we
tested the hypothesis that patients with heart failure who were treated with torsemide, a …

Torsemide vs furosemide among patients with new-onset vs worsening chronic heart failure: a substudy of the TRANSFORM-HF randomized clinical trial

SR Krim, S Anand, SJ Greene, A Chen… - JAMA …, 2024 - jamanetwork.com
Importance Differences in clinical profiles, outcomes, and diuretic treatment effects may exist
between patients with de novo heart failure (HF) and worsening chronic HF (WHF) …

Torsemide versus furosemide in patients with acute heart failure (from the ASCEND-HF Trial)

RJ Mentz, V Hasselblad, AD DeVore, M Metra… - The American journal of …, 2016 - Elsevier
Highlights•Furosemide is the most commonly used loop diuretic in patients with heart failure
despite data suggesting potential pharmacologic and antifibrotic benefits with torsemide.•In …

Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial

RJ Mentz, EJ Velazquez, M Metra, C McKendry… - Future …, 2015 - Taylor & Francis
Aim: The authors assessed the comparative effectiveness of torsemide versus furosemide in
the PROTECT trial. Methods: The authors assessed the relationship between loop diuretic at …

Torsemide comparison with furosemide for management of heart failure (TRANSFORM-HF) trial

FH Verbrugge, V Menon - European Heart Journal: Acute …, 2022 - academic.oup.com
Torsemide comparison with furosemide for management of heart failure (TRANSFORM-HF)
trial Page 1 European Heart Journal: Acute Cardiovascular Care (2022) 11, 931–932 https://doi.org/10.1093/ehjacc/zuac144 …

Effect of torsemide versus furosemide on symptoms and quality of life among patients hospitalized for heart failure: the TRANSFORM-HF randomized clinical trial

SJ Greene, EJ Velazquez, KJ Anstrom, RM Clare… - Circulation, 2023 - Am Heart Assoc
Background: Loop diuretics are a primary therapy for the symptomatic treatment of heart
failure (HF), but whether torsemide improves patient symptoms and quality of life better than …

Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial

RJ Mentz, KJ Anstrom, EL Eisenstein, S Sapp… - Jama, 2023 - jamanetwork.com
Importance Although furosemide is the most commonly used loop diuretic in patients with
heart failure, some studies suggest a potential benefit for torsemide. Objective To determine …